Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000342199

Medchemexpress LLC A-836339 | 959746-77-1 | 99.8% | 1 ML
SDP

Catalog No. 5000342199
Encompass_Preferred

A-836339 is a selective CB2 receptor agonist with Ki values of 0.4 nM in humans and 0.8 nM in rats. It demonstrates various effects, including analgesia, gastric protection, anti-inflammation, and antioxidant activity. This compound achieves antinociceptive and analgesic effects by activating CB2 receptors located in the dorsal root ganglia and spinal cord.

  • Provides gastric protective benefits through anti-inflammatory and antioxidant mechanisms.
  • Can be used as a CB2-specific radioligand for autoradiography and PET imaging.
  • Suitable for research on inflammatory pain, neuropathic pain, gastric ulcers, and cerebral ischemia.

Catalog No. 50-003-42199 Supplier Medchemexpress LLC Supplier No. HY1276110MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

A-836339 is a selective CB2 receptor agonist with Ki values of 0.4 nM in humans and 0.8 nM in rats. It demonstrates various effects, including analgesia, gastric protection, anti-inflammation, and antioxidant activity. This compound achieves antinociceptive and analgesic effects by activating CB2 receptors located in the dorsal root ganglia and spinal cord.

  • Provides gastric protective benefits through anti-inflammatory and antioxidant mechanisms.
  • Can be used as a CB2-specific radioligand for autoradiography and PET imaging.
  • Suitable for research on inflammatory pain, neuropathic pain, gastric ulcers, and cerebral ischemia.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.